Skip to main content
Thoth
Open Book Publishers

  1. Clinical Integration of Maggot Therapy

Export Metadata

Metadata
Title
  1. Clinical Integration of Maggot Therapy
ContributorBenjamin L. Bullen(author)
Ronald A. Sherman (author)
Paul J. Chadwick (author)
Frank Stadler(author)
DOIhttps://doi.org/10.11647/obp.0300.06
Landing pagehttps://www.openbookpublishers.com/books/10.11647/obp.0300/chapters/10.11647/obp.0300.06
Licensehttps://creativecommons.org/licenses/by-nc/4.0/
CopyrightBenjamin L. Bullen; Ronald A. Sherman; Paul J. Chadwick; Frank Stadler
PublisherOpen Book Publishers
Publication placeCambridge, UK
Published on2022-07-20
Long abstract
Page rangepp. 97–118
LanguageEnglish (Original)

Contributors

Benjamin L. Bullen

(author)
Principal Lecturer in Assessment Skills, Simulation and Interprofessional Education, School of Pharmacy at University of Wolverhampton
Honorary Lecturer at School of Medicine at Cardiff University

Ronald A. Sherman

(author)
Director at BioTherapeutics, Education & Research (BTER) Foundation

Paul J. Chadwick

(author)
National Clinical Director at College of Podiatry
Visiting Professor of Tissue Viability at Birmingham City University

Frank Stadler

(author)
Adjunct Fellow at Applied BioSciences at Macquarie University
Adjunct Research Fellow at Griffith University

References

  1. 1. Evans, P., Larvae Therapy and Venous Leg Ulcers: Reducing the ‘Yuk Factor’. Journal of Wound Care, 2002. 11(10): pp. 407–408, https://doi.org/10.12968/jowc.2002.11.10.26445. (opens in new tab)
  2. 2. Humphreys, I., P. Lehane, and Y. Nigam, Could Maggot Therapy Be Taught in Primary Schools? Journal of Biological Education, 2020: pp. 1–11, https://doi.org/10.1080/00219266.2020.1748686. (opens in new tab)
  3. 3. Jones, J., J. Green, and A.K. Lillie, Maggots and Their Role in Wound Care. British Journal of Community Nursing, 2011. 16: pp. S24-S33.
  4. 4. Steenvoorde, P., et al., Maggot Therapy and the “Yuk” Factor: An Issue for the Patient? Wound Repair and Regeneration, 2005. 13(3): pp. 350–352, https://doi.org/10.1111/j.1067-1927.2005.130319.x. (opens in new tab)
  5. 5. Sandelowski, M., What’s in a Name? Qualitative Description Revisited. Research in Nursing and Health, 2010. 33(1): pp. 77–84, https://doi.org/10.1002/nur.20362. (opens in new tab)
  6. 6. Whitaker, I.S., et al., Larval Therapy from Antiquity to the Present Day: Mechanisms of Action, Clinical Applications and Future Potential. Postgraduate Medical Journal, 2007. 83(980): pp. 409–413, https://doi.org/10.1136/pgmj.2006.055905. (opens in new tab)
  7. 7. Dunbar, G., Notes on the Ngemba tribe of the Central Darling River of Western New South Wales. Mankind, 1944. 81: pp. 199–202.
  8. 8. Greenberg, B., Chapter 1: Flies through History, in Flies and Disease: II. Biology and Disease Transmission, B. Greenberg, Editor. 1973, Princeton University Press: Princeton. pp. 2–18.
  9. 9. Weil, J.C., R.J. Simon, and W.R. Sweadner, A Biological, Bacteriological and Clinical Study of Larval or Maggot Therapy in the Treatment of Acute and Chronic Pyogenic Infections. American Journal of Surgery, 1933. 19: pp. 36–48.
  10. 10. Fonder, M.A., et al., Treating the Chronic Wound: A Practical Approach to the Care of Nonhealing Wounds and Wound Care Dressings. Journal of the American Academy of Dermatology, 2008. 58(2): pp. 185–206, https://doi.org/10.1016/j.jaad.2007.08.048. (opens in new tab)
  11. 11. Saraf, S. and R.S. Parihar, Sushruta: The First Plastic Surgeon in 600 B.C. The Internet Journal of Plastic Surgery, 2006. 4(2), https://ispub.com/IJPS/4/2/8232.
  12. 12. The University of Nottingham. We Could Make That!: Chance Meeting Leads to Creation of Antibiotic Spider Silk. https://www.nottingham.ac.uk/news/pressreleases/2017/january/chance-meeting-leads-to-creation-of-antibiotic-spider-silk.aspx.
  13. 13. Drucker, C.B., Ambroise Paré and the Birth of the Gentle Art of Surgery. Yale Journal of Biology and Medicine, 2008. 81(4): pp. 199–202, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605308/.
  14. 14. Larrey, B.D., Observations on Wounds, and Their Complications by Erysipelas, Gangrene and Tetanus, etc. [in French]. Translated from French by E.F. Rivinus. Mielke and Biddle: Philadelphia, 1832.
  15. 15. Baer, W.S., Sacro-iliac Joint-arthritis Deformans-viable Antiseptic in Chronic Osteomyelitis. Interstate Postgraduate Medical Association of North America, 1929. 371: pp. 365–372.
  16. 16. Baer, W.S., The Treatment of Chronic Osteomyelitis with the Maggot (Larva of the Blow Fly). The Journal of Bone and Joint Surgery. American Volume, 1931. 13: pp. 438–475, https://doi.org/10.1007/s11999-010-1416-3. (opens in new tab)
  17. 17. Sherman, R.A., S. Mendez, and C. McMillan. Using Maggots in Wound Care: Part 2. 2014, Wound Care Advisor, https://woundcareadvisor.com/using-maggots-in-wound-care-part-2-vol3-no6/.
  18. 18. BTER Foundation. Policies & Procedures Templates. 2022. https://www.bterfoundation.org/policies-procedures-templates.
  19. 19. BTER Foundation. Welcome to the BTER Foundation. 2022, https://www.bterfoundation.org.
  20. 20. NHS England. NHS Five Year Forward View. 2014. https://www.england.nhs.uk/five-year-forward-view.
  21. 21. NHS England. NHS Long Term Plan. 2019. https://www.england.nhs.uk/long-term-plan.
  22. 22. National Health Executive. The Benefit of Growing at Scale. 2015. https://www.nationalhealthexecutive.com/Editors-Comment/the-benefit-of-growing-at-scale.
  23. 23. Takáč, P., et al., and F. Stadler, Establishment of a Medicinal Maggot Production Facility and Treatment Programme in Kenya, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 331–346, https://doi.org/10.11647/OBP.0300.15.(opens in new tab)
  24. 24. Bojke, C., et al. Economic Evaluation of a Treatment for Non-healing Wounds with Observational Data: An Example of a Topical Haemoglobin Spray for the Treatment of Diabetic Foot Ulcers. 2019, https://medicinehealth.leeds.ac.uk/download/downloads/id/402/wp19-01_-_b_bojke_et_al_b_-_economic_evaluation_of_a_treatment_for_non-healing_wounds_with_observational_data_%E2%80%93_an_example_of_a_topical_haemoglobin_spray_for_the_treatment.pdf.
  25. 25. FDA. 510(k) Summary. Monarch Labs, LLC. 2007. https://www.accessdata.fda.gov/cdrh_docs/pdf7/K072438.pdf.
  26. 26. Sherman, R.A., Maggot Therapy Takes Us back to the Future of Wound Care: New and Improved Maggot Therapy for the 21st Century. Journal of Diabetes Science and Technology, 2009. 3(2): pp. 336–344, https://doi.org/10.1177/193229680900300215. (opens in new tab)
  27. 27. Alfaro, M., et al., National Health Systems and COVID-19 Death Toll Doubling Time. Frontiers in Public Health, 2021. 9, https://doi.org/10.3389/fpubh.2021.669038. (opens in new tab)
  28. 28. Beveridge, W. The Beveridge Report: Social Insurance and Allied Services. 1942. https://dspace.gipe.ac.in/xmlui/bitstream/handle/10973/32621/GIPE-033701-Contents.pdf?sequence=2&isAllowed=y.
  29. 29. Wallace, L.S., A View of Health Care around the World. Annals of Family Medicine, 2013. 11(1): p. 84, https://doi.org/10.1370/afm.1484. (opens in new tab)
  30. 30. Hanratty, M.J., Canadian National Health Insurance and Infant Health. The American Economic Review, 1996. 86(1): pp. 276–284, https://www.jstor.org/stable/2118267.
  31. 31. National Institute for Health and Care Excellence. Chronic Wounds: Advanced Wound Dressings and Antimicrobial Dressings. 2016. https://www.nice.org.uk/advice/esmpb2/chapter/Key-points-from-the-evidence.
  32. 32. Courtenay, M., The Use of Larval Therapy in Wound Management in the UK. Journal of Wound Care, 1999. 8(4): pp. 177–179, https://doi.org/10.12968/jowc.1999.8.4.25866. (opens in new tab)
  33. 33. Evans, H., A Treatment of Last Resort. Nursing Times, 1997. 93(23): pp. 62–65.
  34. 34. Journal of Wound Care. Wound Care Handbook: Negative Pressure Wound Therapy. 2022. https://www.woundcarehandbook.com/configuration/categories/wound-care/negative-pressure-wound-therapy.
  35. 35. Stadler, F., The Maggot Therapy Supply Chain: A Review of the Literature and Practice. Med Vet Entomol, 2020. 34(1): pp. 1–9, https://doi.org/10.1111/mve.12397. (opens in new tab)
  36. 36. BioMonde. Larval Debridement Therapy: Making Healing Possible. 2022. https://biomonde.com/en.
  37. 37. Monarch Labs. Monarch Labs: Living Medicine. 2022. https://www.monarchlabs.com.
  38. 38. Paul, A.G., et al., Maggot Debridement Therapy with Lucilia cuprina: A Comparison with Conventional Debridement in Diabetic Foot Ulcers. International Wound Journal, 2009. 6(1): pp. 39–46, https://doi.org/10.1111/j.1742-481X.2008.00564.x. (opens in new tab)
  39. 39. Sherman, R.A., M.J.R. Hall, and S. Thomas, Medicinal Maggots: An Ancient Remedy for Some Contemporary Afflictions. Annual Review of Entomology, 2000. 45(1): pp. 55–81, https://doi.org/10.1146/annurev.ento.45.1.55. (opens in new tab)
  40. 40. Thyssen, P.J. and F.S. Masiero, Bioprospecting and Testing of New Fly Species for Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 195–234, https://doi.org/10.11647/OBP.0300.11.(opens in new tab)
  41. 41. Stadler, F., et al., Fly Colony Establishment, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 257–288 (p. 269), https://doi.org/10.11647/OBP.0300.13.(opens in new tab)
  42. 42. Čičková, H., M. Kozánek, and P. Takáč, Growth and Survival of Blowfly Lucilia sericata Larvae under Simulated Wound Conditions: Implications for Maggot Debridement Therapy. Medical and Veterinary Entomology, 2015. 29(4): pp. 416–424, https://doi.org/10.1111/mve.12135. (opens in new tab)
  43. 43. Chadwick, P., et al., Appropriate Use of Topical Haemoglobin in Chronic Wound Management: Consensus Recommendations. The Diabetic Foot Journal, 2015. 18(3): pp. 142–146, https://diabetesonthenet.com/diabetic-foot-journal/appropriate-use-of-topical-haemoglobin-in-chronic-wound-management-consensus-recommendations-2/.
  44. 44. Foley, E., A. Robinson, and M. Maloney, Skin Substitutes and Dermatology: A Review. Current Dermatology Reports, 2013. 2(2): pp. 101–112.
  45. 45. Snyder, D.L., et al. Skin Substitutes for Treating Chronic Wounds. 2020. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/comments/skin-substitutes-disposition-of-comments.pdf.
  46. 46. Sherman, R.A. and F.A. Wyle, Low-cost, Low-maintenance Rearing of Maggots in Hospitals, Clinics, and Schools. American Journal of Tropical Medicine and Hygiene, 1996. 54(1): pp. 38–41, https://doi.org/10.4269/ajtmh.1996.54.38. (opens in new tab)
  47. 47. Stadler, F., R.Z. Shaban, and P. Tatham, Maggot Debridement Therapy in Disaster Medicine. Prehospital and Disaster Medicine, 2016. 31(1): pp. 79–84, https://doi.org/10.1017/s1049023x15005427. (opens in new tab)
  48. 48. Chadwick, P., et al., Appropriate Use of Larval Debridement Therapy in Diabetic Foot Management: Consensus Recommendations. Diabetic Foot Journal, 2015. 18(1): pp. 37–42, https://diabetesonthenet.com/wp-content/uploads/dfj18-1-37-42-1.pdf.
  49. 49. Beliën, J. and H. Forcé, Supply Chain Management of Blood Products: A Literature Review. European Journal of Operational Research, 2012. 217(1): pp. 1–6, https://doi.org/10.2139/ssrn.1974803. (opens in new tab)
  50. 50. Kumru, O.S., et al., Vaccine Instability in the Cold Chain: Mechanisms, Analysis and Formulation Strategies. Biologicals, 2014. 42(5): pp. 237–259, https://doi.org/10.1016/j.biologicals.2014.05.007. (opens in new tab)
  51. 51. Peck, G., et al., Airworthiness Testing of Medical Maggots. Military Medicine, 2015. 180(5): pp. 591–596, https://doi.org/10.7205/MILMED-D-14-00548. (opens in new tab)
  52. 52. Tatham, P., et al., Flying Maggots: A Smart Logistic Solution to an Enduring Medical Challenge. Journal of Humanitarian Logistics and Supply Chain Management, 2017. 7(2): pp. 172–193, https://dx.doi.org/10.1108/JHLSCM-02-2017-0003. (opens in new tab)
  53. 53. Stadler, F. and P. Tatham, Drone-assisted Medicinal Maggot Distribution in Compromised Healthcare Settings, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 383–402, https://doi.org/10.11647/OBP.0300.18.(opens in new tab)
  54. 54. Stadler, F., Distribution Logistics, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 363–382, https://doi.org/10.11647/OBP.0300.17.(opens in new tab)
  55. 55. Sherman, R., Medicinal Maggot Application and Maggot Therapy Dressing Technology, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 79–96, https://doi.org/10.11647/OBP.0300.05.(opens in new tab)
  56. 56. Stadler, F., The Ethics of Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 405–430, https://doi.org/10.11647/OBP.0300.19.(opens in new tab)
  57. 57. Davey, G.C., Self-reported Fears to Common Indigenous Animals in an Adult UK Population: The Role of Disgust Sensitivity. British Journal of Psychology, 1994. 85 (Pt 4): p. 541–554, https://doi.org/10.1111/j.2044-8295.1994.tb02540.x. (opens in new tab)
  58. 58. Sherman, R. and F. Stadler, Wound Aetiologies, Patient Characteristics, and Healthcare Settings Amenable to Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 39–62, https://doi.org/10.11647/OBP.0300.03.(opens in new tab)
  59. 59. Sherman, R., Indications, Contraindications, Interactions, and Side-effects of Maggot Therapy, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 63–78, https://doi.org/10.11647/OBP.0300.04.(opens in new tab)
  60. 60. Stadler, F., Supply Chain Management for Maggot Debridement Therapy in Compromised Healthcare Settings. 2018. Unpublished doctoral dissertation, Griffith University, Queensland, https://doi.org/10.25904/1912/3170.
  61. 61. National Institute for Health and Care Excellence. NG19: The Diabetic Foot (updated 2019) 2015. https://www.nice.org.uk/guidance/ng19/evidence/full-guideline--august-2015-pdf-15672915543.
  62. 62. International Working Group on the Diabetic Foot. IWGDF Practical Guidelines on the Prevention and Management of Diabetic Foot Disease. 2019. https://iwgdfguidelines.org/wp-content/uploads/2021/03/IWGDF-2019-final.pdf.
  63. 63. Conte, M.S., et al., Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery, 2019. 58(1s): pp. S1-S109.e33, https://doi.org/10.1016/j.ejvs.2019.05.006. (opens in new tab)
  64. 64. National Institute for Health and Care Excellence. Lower Limb Pathways. 2019. https://pathways.nice.org.uk/pathways/lower-limb-peripheral-arterial-disease.
  65. 65. National Institute for Health and Care Excellence. Venous Disease. 2020. https://cks.nice.org.uk/topics/leg-ulcer-venous/management/venous-leg-ulcers.
  66. 66. European Pressure Ulcer Advisory Panel. New Guidelines. 2019. https://www.epuap.org/pu-guidelines.
  67. 67. Chan, D.C., et al., Maggot Debridement Therapy in Chronic Wound Care. Hong Kong Medical Journal, 2007. 13(5): pp. 382–386, https://www.hkmj.org/abstracts/v13n5/382.htm.
  68. 68. Sherman, R.A. and R. Chon, BioTherapeutics, Education and Research Foundation Position Paper: Assessing the Competency of Clinicians Performing Maggot Therapy. Wound Repair and Regeneration, 2022. 30(1): pp. 100–106, https://doi.org/10.1111/wrr.12986. (opens in new tab)
  69. 69. BioMonde. Introducing Larval Academy. 2021. https://biomonde.com/en/hcp/elearning/larval-academy.
  70. 70. Mexican Association for Wound Care and Healing. Clinical Practice Guidelines for the Treatment of Acute and Chronic Wounds with Maggot Debridement Therapy. 2010. https://s3.amazonaws.com/aawc-new/memberclicks/GPC_larvatherapy.pdf.
  71. 71. Mirabzadeh, A., et al., Maggot Therapy for Wound Care in Iran: A Case Series of the First 28 Patients. Journal of Wound Care, 2017. 26(3): pp. 137–143, https://doi.org/10.12968/jowc.2017.26.3.137. (opens in new tab)
  72. 72. All Wales Tissue Viability Nurse Forum. The All Wales Guidance for the Use of Larval Debridement Therapy (LDT). 2013. https://www.wounds-uk.com/download/resource/5850.
  73. 73. Stadler, F. Supply Chain Management for Maggot Debridement Therapy in Compromised Healthcare Settings. 2018. Unpublished doctoral dissertation, Griffith University, Queensland, https://doi.org/10.25904/1912/3170.
  74. 74. Stadler, F., Laboratory and Insectary Infrastructure and Equipment, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 237–256, https://doi.org/10.11647/OBP.0300.12.(opens in new tab)
  75. 75. Stadler, F., Packaging Technology, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 349–362, https://doi.org/10.11647/OBP.0300.16.(opens in new tab)
  76. 76. Stadler, F. and P. Takáč, Medicinal Maggot Production, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 289–330, https://doi.org/10.11647/OBP.0300.14.(opens in new tab)